Skip to content
NJ News HubNewsHub

Business

Quest Diagnostics names Merck vet Chokshi as vice president, investor relations

Source: ROI-NJ · Jul 30, 2026, 9:44 AM

AI-assisted briefing from the publisher’s public headline and excerpt — not original reporting. How we write briefings

Quest Diagnostics names Merck vet Chokshi as vice president, investor relations news image

Quest Diagnostics, the Secaucus-based diagnostic testing company, has appointed Damini Chokshi as vice president of investor relations.

Chokshi brings nearly 20 years of experience in investor relations and finance roles at pharmaceutical giant Merck & Co.

In his new position, Chokshi will lead the development, design, and implementation of Quest's investor relations strategy and programs while providing strategic guidance to the company's leadership.

The appointment reflects Quest's continued focus on strengthening its investor communications and corporate strategy as the company maintains its position as a leading provider of diagnostic information services.

Key points

  • Damini Chokshi joins Quest Diagnostics from Merck & Co. with nearly 20 years of investor relations and finance experience
  • Chokski will oversee development and implementation of Quest's investor relations strategy and programs
  • Quest Diagnostics is based in Secaucus, New Jersey and is a major diagnostic testing provider
  • The appointment signals the company's focus on enhancing investor communications and strategic guidance

FAQ

Who is Damini Chokshi and what is his background?
Damini Chokshi is a business executive who spent nearly 20 years in investor relations and finance roles at Merck & Co., one of the world's largest pharmaceutical companies. He brings extensive experience in corporate finance and investor strategy to his new role.
What will Chokshi's responsibilities be at Quest Diagnostics?
As vice president of investor relations, Chokski will lead the development, design, and implementation of Quest's investor relations strategy and programs. He will also provide strategic insight and guidance to the company's leadership team.
Why does this appointment matter for Quest Diagnostics?
The appointment demonstrates Quest's commitment to strengthening its investor communications and corporate strategy. Bringing in a seasoned executive from a major pharmaceutical company helps enhance Quest's engagement with investors and shareholders.

Briefing prepared for NJ News Hub. Verify details on the original story. See our editorial policy.

Related